Lexicon Pharmaceuticals
LXRX
#7435
Rank
$0.42 B
Marketcap
$1.17
Share price
-0.85%
Change (1 day)
72.06%
Change (1 year)

P/S ratio for Lexicon Pharmaceuticals (LXRX)

P/S ratio as of December 2025 (TTM): 5.78

According to Lexicon Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.41. At the end of 2025 the company had a P/S ratio of 7.18.

P/S ratio history for Lexicon Pharmaceuticals from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20257.18-20.19%
20249.00-97.11%
2023311-88.01%
2022> 100031.73%
2021> 10009661.37%
202020.21372.78%
20191.37-87.63%
201811.1-4.13%
201711.5-33.11%
201617.362.75%
201510.6-63.22%
201428.8-93.06%
2013416-60.01%
2012> 1000341.36%
2011236137.98%
201099.0254.62%
200927.9371.12%
20085.93-28.35%
20078.27114.35%
20063.8623.92%
20053.11-60.96%
20047.97-7.68%
20038.6422.76%
20027.04258.18%
20011.96

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Eterna Therapeutics
ERNA
> 1000 172,536.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
5.72-0.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
5.18-10.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.84-33.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
4.88-15.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
3.10-46.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
4.79-17.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
15.7 171.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
3.52-39.02%๐Ÿ‡บ๐Ÿ‡ธ USA